mounjaro semaglutide or tirzepatide In adults with obesity but not diabetes, leads to significantly greater weight loss than over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Wegovy vs Mounjaro for Weight
Description
2025 May 9

Specific warning: Retatrutide Retatrutide is a potential medicine that is still being studied

The visual inspection principles in this guide are specifically for injectable semaglutide

Novo Nordisk A/S launched a competing GLP-1 agonist (Tirzepatide), growing market competitiveness & indirectly prompting Sweden's semaglutide sales trajectory

Clinical trial results at a glance The clinical trial data around oral GLP-1s is already highly encouraging
